Dr. Reddy’s revenues cross $2 billion milestone in FY12
Mumbai, India, May 11th, 2012: Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its audited consolidated financial results for the quarter and full year ended March 31, 2012 under International Financial Reporting Standards (IFRS). Key Highlights oConsolidated revenues at `96.7 billion in FY12, year-on-year growth of 30%, driven by key markets of North America and …
Click here to read full Press Release